These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7573606)

  • 1. Lithium or desipramine augmentation of fluoxetine treatment.
    Nelson JC; Price LH
    Am J Psychiatry; 1995 Oct; 152(10):1538-9. PubMed ID: 7573606
    [No Abstract]   [Full Text] [Related]  

  • 2. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.
    Fava M; Rosenbaum JF; McGrath PJ; Stewart JW; Amsterdam JD; Quitkin FM
    Am J Psychiatry; 1994 Sep; 151(9):1372-4. PubMed ID: 8067495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine and desipramine: a strategy for augmenting anti-depressant response.
    Eisen A
    Pharmacopsychiatry; 1989 Nov; 22(6):272-3. PubMed ID: 2616636
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequence of drug administration in lithium augmentation: a case study.
    Price LH; Delgado PL; Charney DS; Heninger GR
    J Clin Psychiatry; 1988 Apr; 49(4):161-2. PubMed ID: 3356674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression.
    Fontaine R; Ontiveros A; Elie R; Vézina M
    Biol Psychiatry; 1991 May; 29(9):946-8. PubMed ID: 1904782
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible synergism between fluoxetine and lithium in refractory depression.
    Pope HG; McElroy SL; Nixon RA
    Am J Psychiatry; 1988 Oct; 145(10):1292-4. PubMed ID: 3262313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg/day.
    Perlis RH; Alpert J; Nierenberg AA; Mischoulon D; Yeung A; Rosenbaum JF; Fava M
    Acta Psychiatr Scand; 2003 Dec; 108(6):432-8. PubMed ID: 14616224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
    Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
    J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fluoxetine on plasma desipramine and 2-hydroxydesipramine.
    Suckow RF; Roose SP; Cooper TB
    Biol Psychiatry; 1992 Jan; 31(2):200-4. PubMed ID: 1737080
    [No Abstract]   [Full Text] [Related]  

  • 11. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression.
    Nelson JC; Mazure CM; Bowers MB; Jatlow PI
    Arch Gen Psychiatry; 1991 Apr; 48(4):303-7. PubMed ID: 2009031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients.
    Austin LS; Arana GW; Melvin JA
    J Clin Psychiatry; 1990 Aug; 51(8):344-5. PubMed ID: 2380160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium and desipramine versus desipramine alone in the treatment of severe major depression: a preliminary study.
    Cappiello A; McDougle CJ; Delgado PL; Malison RT; Jatlow P; Charney DS; Heninger GR; Price LH
    Int Clin Psychopharmacol; 1998 Sep; 13(5):191-8. PubMed ID: 9817623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine inhibits desipramine metabolism.
    Wilens TE; Biederman J; Baldessarini RJ; McDermott SP; Puopolo PR; Flood JG
    Arch Gen Psychiatry; 1992 Sep; 49(9):752. PubMed ID: 1514882
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated tricyclic antidepressant plasma concentrations associated with fluoxetine: two case reports.
    Michals M; Stanley DA; Crismon ML; Barrow NE
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):466-7. PubMed ID: 2136405
    [No Abstract]   [Full Text] [Related]  

  • 16. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
    Oliveto A; Kosten TR; Schottenfeld R; Falcioni J; Ziedonis D
    J Subst Abuse Treat; 1995; 12(6):423-8. PubMed ID: 8749726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory depression: the addition of lithium to fluoxetine or desipramine.
    Ontiveros A; Fontaine R; Elie R
    Acta Psychiatr Scand; 1991 Mar; 83(3):188-92. PubMed ID: 1903237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a case report.
    Howland RH
    Can J Psychiatry; 1991 Mar; 36(2):154-5. PubMed ID: 1904303
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolerability of combined treatment with lithium and fluoxetine: 14 cases treated under open conditions.
    Hawley CJ; Roberts AG; Baldwin DS
    Int Clin Psychopharmacol; 1994; 9(1):31-3. PubMed ID: 8195580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying depression secondary to lithium-induced hypothyroidism.
    Sternbach HA; Pottash AL; Extein I; Gold MS
    Psychosomatics; 1984 Nov; 25(11):864-6. PubMed ID: 6505132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.